Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease

被引:169
|
作者
Kania, Gabriela [2 ]
Blyszczuk, Przemyslaw [2 ]
Eriksson, Urs [1 ]
机构
[1] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Inst Physiol, Dept Cardiovasc Res, CH-8057 Zurich, Switzerland
关键词
EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; MARROW-DERIVED CELLS; HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR; ENTEROVIRUS MYOCARDITIS; MAST-CELLS; TGF-BETA; MYOFIBROBLASTS; CARDIOMYOPATHY; PATHOGENESIS;
D O I
10.1016/j.tcm.2010.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart injury from many causes can end up in a common final pathway of pathologic remodeling and fibrosis, promoting heart failure development. Dilated cardiomyopathy is an important cause of heart failure and often results from virus-triggered myocarditis. Monocytes and monocyte-like cells represent a major subset of heart-infiltrating cells at the injury site. These bone marrow-derived cells promote not only tissue injury in the short term but also angiogenesis and collagen deposition in the long term. Thus, they are critically involved in the typical tissue fibrosis, which evolves in the dilating ventricle during the process of pathologic remodeling. Recent findings suggest that heart-infiltrating monocyte-like cells indeed contain a pool of progenitors, which represent the cellular source both for accumulation of differentiated monocytes during the acute inflammatory phase and for transforming growth factor-beta-mediated myocardial fibrosis during the later chronic stages of disease. Obviously, a delicate balance of proinflammatory and pro fibrotic cytokines dictates the fate of bone marrow-derived heart-infiltrating progenitors and directly influences the morphologic phenotype of the affected heart. In this minireview, we provide an update on these mechanisms and discuss their significance in pathologic remodeling and heart failure progression after myocarditis. (Trends Cardiovasc Med 2009;19:247-252) (C) 2009, Elsevier Inc.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [41] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02): : 115 - 126
  • [42] MECHANISMS OF DISEASE - IMMUNE-MECHANISMS OF CARDIAC DISEASE
    LANGE, LG
    SCHREINER, GF
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (16): : 1129 - 1135
  • [43] Cardiac Fibrosis and Changes in Left Ventricle Function in Patients with Chronic Chagas Heart Disease
    de Figueiredo Santos, Joao Bosco
    Gottlieb, Ilan
    Tassi, Eduardo Marinho
    Camargo, Gabriel Cordeiro
    Atie, Jacob
    Xavier, Sergio Salles
    Pedrosa, Roberto Coury
    Saraiva, Roberto Magalhaes
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (06) : 1081 - 1089
  • [44] Different Disease States in Heart Have Distinct Cardiac Interstitial Cells Contributing to Fibrosis
    Khalil, Hadi
    Jones, Shannon M.
    Alam, Perwez
    Aronow, Bruce J.
    Molkentin, Jeffery D.
    Kanisicak, Onur
    CIRCULATION RESEARCH, 2019, 125
  • [45] CARDIAC AUTONOMIC CONTROL MECHANISMS IN CHAGAS HEART-DISEASE - THERAPEUTIC IMPLICATIONS
    DAVILA, DF
    BELLABARBRA, G
    DONIS, JH
    TORRES, A
    ROSSELL, OJ
    FIGUEROA, O
    AMARO, M
    VASQUEZ, CJ
    MEDICAL HYPOTHESES, 1993, 40 (01) : 33 - 37
  • [46] RELATIONSHIP OF CARDIAC MAGNETIC RESONANCE-DERIVED MYOCARDIAL FIBROSIS WITH CARDIAC GEOMETRY AND STRAIN IN HYPERTENSIVE HEART DISEASE
    Pichler, G.
    Martinez Garcia, F.
    Ruiz Hernandez, A.
    Belmonte Domingo, A.
    Calaforra Juan, O.
    Solaz Moreno, E.
    San Andres Marco, M.
    Redon, J.
    Maceira Gonzalez, A.
    JOURNAL OF HYPERTENSION, 2018, 36 : E230 - E230
  • [47] 'Targeting the cardiac myocyte and fibrosis' in heart failure
    Ishiura, Junko
    Nakamori, Shiro
    Ishida, Masaki
    Dohi, Kaoru
    EUROPEAN HEART JOURNAL, 2022, 43 (05) : 432 - 432
  • [48] Inflammatory myopathies: disease mechanisms
    Greenberg, Steven A.
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (05) : 516 - 523
  • [49] Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
    Friedman, Scott L.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 98 - 105
  • [50] Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
    Scott L Friedman
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 98 - 105